Latest News
Parallel Trade – A reminder
Following a government consultation, updated guidance on the application and implications of Intellectual Property (IP) restrictions has been published. Essentially there is no change to the rules that were established following Brexit, but it is important for businesses who participate in this trading style are aware of the rules.
Journalists – Be Careful What You Write About Medicines
The MHRA continue to scrutinise and take action against Pharmacies and Clinics who are promoting Prescription Only Medicines (POMs) to the public. However, this month’s advertising investigations bulletin also includes action against a journalist newspaper article.
Responsible Person for Import Role after the Windsor Framework
The Responsible Person for Import (RPi) is an important role to maintain oversight of the supply chain of medicines imported for use in the UK.